RATIOS
Kilitch Drugs(I) Ltd.
BSE
Jul 21, 04:01
445.10
+0.15 (+ 0.03%)
Volume
2777
Prev. Close
444.95
Open Price
436.10
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
NSE
Jul 21, 03:16
449.00
+7.85 (+ 1.78%)
Volume
4925
Prev. Close
441.15
Open Price
433.05
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
You can view the
Ratio Analysis
for the last 5 years.
|
ISIN No
|
INE729D01010
|
Market Cap. ( ₹ in Cr. )
|
784.89
|
P/BV
|
3.11
|
Book Value ( ₹ )
|
144.30
|
|
BSE Code
|
524500
|
52 Week High/Low ( ₹ )
|
500/305
|
FV/ML
|
10/1
|
P/E(X)
|
29.82
|
|
NSE Code
|
KILITCHBE
|
Book Closure
|
15/07/2025
|
EPS ( ₹ )
|
15.06
|
Div Yield (%)
|
0.00
|
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | | |
| PER SHARE RATIOS | | | | | |
| | | | | | |
| Basic EPS (Rs.) | 19.37 | 11.03 | 10.09 | 6.76 | 3.98 |
| Diluted EPS (Rs.) | 19.37 | 11.03 | 10.09 | 6.76 | 3.98 |
| Cash EPS (Rs.) | 20.45 | 11.70 | 10.94 | 7.37 | 4.71 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 157.28 | 138.61 | 125.74 | 114.25 | 105.16 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 157.28 | 138.61 | 125.74 | 114.25 | 105.16 |
| Revenue From Operations / Share (Rs.) | 112.91 | 81.83 | 75.59 | 67.49 | 45.19 |
| PBDIT / Share (Rs.) | 27.70 | 16.48 | 13.97 | 9.98 | 6.07 |
| PBIT / Share (Rs.) | 26.62 | 15.71 | 13.11 | 9.36 | 5.33 |
| PBT / Share (Rs.) | 25.30 | 14.52 | 12.48 | 8.94 | 4.84 |
| Net Profit / Share (Rs.) | 19.37 | 10.93 | 10.09 | 6.76 | 3.97 |
| | | | | | |
| PROFITABILITY RATIOS | | | | | |
| | | | | | |
| PBDIT Margin (%) | 24.53 | 20.14 | 18.48 | 14.79 | 13.43 |
| PBIT Margin (%) | 23.57 | 19.19 | 17.34 | 13.87 | 11.80 |
| PBT Margin (%) | 22.40 | 17.74 | 16.51 | 13.24 | 10.72 |
| Net Profit Margin (%) | 17.15 | 13.35 | 13.34 | 10.01 | 8.79 |
| Return on Networth / Equity (%) | 12.31 | 7.88 | 8.02 | 5.91 | 3.77 |
| Return on Capital Employeed (%) | 15.23 | 11.32 | 10.42 | 8.18 | 5.05 |
| Return On Assets (%) | 8.69 | 6.11 | 6.22 | 4.53 | 3.14 |
| Long Term Debt / Equity (X) | 0.10 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Debt / Equity (X) | 0.19 | 0.14 | 0.11 | 0.11 | 0.09 |
| Asset Turnover Ratio (%) | 0.56 | 0.48 | 0.48 | 0.49 | 0.37 |
| | | | | | |
| LIQUIDITY RATIOS | | | | | |
| | | | | | |
| Current Ratio (X) | 2.10 | 2.20 | 2.03 | 1.81 | 2.21 |
| Quick Ratio (X) | 1.91 | 2.14 | 2.00 | 1.72 | 2.10 |
| Inventory Turnover Ratio (X) | 9.66 | 21.99 | 16.54 | 14.04 | 8.31 |
| | | | | | |
| COVERAGE RATIOS | | | | | |
| | | | | | |
| Interest Coverage Ratio (%) | 20.96 | 13.89 | 22.10 | 23.47 | 12.47 |
| Interest Coverage Ratio (Post Tax) (%) | 15.66 | 10.21 | 16.95 | 16.89 | 9.16 |
| | | | | | |
| VALUATION RATIOS | | | | | |
| | | | | | |
| Enterprise Value (Cr.) | 622.93 | 639.66 | 221.35 | 279.20 | 134.52 |
| EV / Net Operating Revenue (X) | 3.43 | 4.86 | 1.88 | 2.65 | 1.92 |
| EV / EBITDA (X) | 13.98 | 24.13 | 10.17 | 17.95 | 14.30 |
| MarketCap / Net Operating Revenue (X) | 3.20 | 4.76 | 1.85 | 2.48 | 1.79 |
| Price / BV (X) | 2.30 | 2.81 | 1.11 | 1.47 | 0.77 |
| Price / Net Operating Revenue (X) | 3.20 | 4.76 | 1.85 | 2.48 | 1.79 |
| EarningsYield | 0.05 | 0.02 | 0.07 | 0.04 | 0.04 |